Effects of the Treatment of Carpal Tunnel Syndrome with Surgery and Injections on the Hospital Anxiety and Depression Scale (HADS)

Background: The prevalence of carpal tunnel syndrome (CTS) and of anxiety and depression in primary care practice are high. Different studies had shown an increased prevalence of anxiety and depression in CTS patients. Nevertheless, few papers had been published studying the anxiety and depression scales in the treatment of CTS, either with corticosteroid injections (I) or with surgical decompression (S). Objective: To assess whether clinical improvement observed after the treatment of CTS either with I or with S correlates with an improvement in the punctuations of the Hospital Anxiety and Depression scales (HADS), at 3, 6 and 12-month follow-up. Methods: Randomized and open-label clinical trial, comparing I and S. Patients with symptoms suggestive of CTS (nocturnal paraesthesias) of at least 3 months duration and neurophysiological confirmation were included. Patients with clinically apparent motor impairment were excluded. The subjective evaluation of symptoms was carried out using the visual-analogue scale of pain (VAS-p). Clinical reviews were performed 3, 6 and 12 months after treatment. Each patient completed the HADS questionnaire and a VAS-p at 0, 3, 6, and 12 months. Statistical significance was established using the Student’s t test and the Mann-Whitney U test when necessary. A linear regression analysis was used to know the effect of the treatment adjusted for the initial score of both scales. Results: 65 patients were included (30 in group I and 35 in group S). There was no statistical difference between both groups in terms of age, gender distribution, disease duration, VAS-p, neurophysiological testing severity of CTS or the 8 subscales of HADS. Both groups improved significantly in relation to the baseline VAS-p values, in the reviews at 3, 6 and 12 months, with no significant differences between I and S. At 6 months, the reduction in the anxiety scale was around 3 points for both treatments (S = 3.6 and I = 3.2), without reaching significant differences. At 12 months, it was somewhat higher for those treated with I, but always around 3 points and without significant differences. The Depression scale score was slightly reduced at 6 months, and in a similar way for both groups (I = 1 and S = 1.19;p = 0.8). After 12 months, group I doubled the previous reduction, with group S experiencing a very slight change (I = 1.96 and S = 1.03;p = 0.3). When analysing the effect of group S on group I, the result was a reduction of 0.25 points for Anxiety (p = 0.7) and of 0.02 points for Depression (p = 0.9). Conclusions: Treatment of CTS with I or S results in a similar and discrete improvement in Anxiety scores on the HADS scale at 6 and 12 months. For both types of treatment, the Depression scores barely changed at 6 months, being somewhat higher in group I after 12-month follow-up. The independent effect of the S on both scales is small and not significant.

Evaluation of the Relationship between the Levels of Knowledge about Prostate Cancer and the Anxiety-Depression Scale of Adult Individuals in Four Different Provinces of Türkiye

Prostate cancer is one of the most common types of cancer in men. The rate of early detection of prostate cancer is low in Türkiye. Therefore, it is important to measure the level of awareness regarding prostate cancer. In our research, we investigate the knowledge levels of prostate cancer among adult individuals in four different geographic region in Türkiye. In addition, we aimed to compare the level of awareness regarding prostate cancer and the depression and anxiety levels among the individuals. The prostate cancer awareness level survey was selected as the data collection tool. In the survey, 20 questions are asked to measure the knowledge level of the participants about prostate cancer. In addition, an evaluation of anxiety and depression was conducted by using the Hospital Anxiety and Depression Scale (HADS). Between April 2022 and December 2022, 834 participants were reached.72.9% of the participants answered the questionnaire correctly. A significant difference was found in terms of correct response rates in four different provinces located in four different regions of Türkiye (79% in Eskisehir, 75.2% in Canakkale, 73% in Ankara, and 54.4% in Maras;p < 0.05). According to the HADS scale, 240 (28.8%) individuals were found to have anxiety and 129 (15.5%) of them had depression. The knowledge level of most of the participants about prostate cancer was found to be above the average. There was a significant difference between provinces in terms of knowledge levels. A significant relationship was observed between depression and knowledge level. However, no significant difference was found for anxiety.

DHI量表和HADS量表在外周性眩晕疾病中的应用

目的应用眩晕残障程度评定量表(DHI)、医院焦虑抑郁量表(HADS)分析外周性眩晕的影响因素。方法选取科室2017年9月-2019年9月外周性眩晕患者286例,头晕/眩晕患者填写DHI量表,包括总分、DHIF(功能性指数)、DHIE(情绪性指数)和DHIP(躯体性指数),同时填写HADS量表,包括HADS-A(焦虑指数)、HADS-D(抑郁指数)。结果治疗后3个月后,患者的DHI、HADS各项指数评分较治疗前显著降低,差异具有统计学意义(P<0.05)。结论 DHI量表和HADS量表评分变化反映了外周性眩晕患者多伴焦虑抑郁症状,通过及时有效的干预,能缓解头晕/眩晕症状,改善患者预后。

五行音乐疗法对跨文化压力探索性试点研究

目的探讨五行音乐疗法(FEMT)对不同文化背景下压力的有效性,并比较五行音乐疗法(FEMT)与西方艺术音乐疗法(WAMT)在缓解压力的差异。方法采用探索性随机对照试点研究,共纳入37名受试者,中方脱落2例,最终纳入35例,其中23名来自加拿大、12名来自中国。知情同意后,所有受试者被随机分配在家中听中医五行音乐或西方艺术音乐30 min,每周2次,持续4周。参与者被要求使用耳机,每次会议前后均测量脉搏率,并填写5份问卷,包括背景和人口统计调查(报告年龄、性别、教育、文化背景、聆听经验)。压力自我评估(每次干预前后),综合医院焦虑/抑郁量表(HADS,第2次干预后每周1次),压力感知调查(PSS,第2次干预后每周1次),音乐治疗干预调查(MTIS,每次干预前后)。结果①与WAMT组相比,FEMT第2次治疗后自我评估的压力评分显著下降(t=-2.057,P=0.046)。②在两组中,每组治疗前的压力评分均显著降低(WAMT:t=5.026;FEMT:T=7.645,P=0.000)。③两组干预后HADS评分差异无统计学意义(P>0.05);在中国样本中,FEMT和WAMT组第八次治疗后HADS评分存在显著差异(t=-3.862,P=0.003),FEMT干预前后HADS的差异有统计学意义(t=5.117,P=0.004)。WAMT组的MTIS治疗前后有显著差异(t=-2.572,P=0.023),但FEMT组没有(t=1.331,P=0.207)。结论该试点研究探索了一种安全可行的自我管理方法-音乐疗法干预两个不同文化群体的压力,并首次提供了FEMT和WAMT在缓解压力和焦虑方面的有效性的初步比较和证据。需要对更大的随机样本进行进一步调查,以阐明不同类型的音乐和文化群体对压力和焦虑水平的影响。

医院焦虑抑郁量表在健康体检中心应用的信度和效度研究

目的验证医院焦虑抑郁量表(HADS)的信度和效度,探讨其在健康体检中心的适用性。方法对随机抽取的健康体检者进行医院焦虑抑郁量表(HADS)自填式问卷调查,采用验证性因子分析方法判断量表的结构效度,Cronbach's系数考核量表的信度。结果因子分析证实HADS存在焦虑和抑郁两个内在因子,与原作者的结构模型不同的是,焦虑分量表中的反向条目和抑郁分量表中的正向条目在原分量表中因子负荷变小。信度分析表明焦虑、抑郁分量表的系数分别为0.71、0.67,HADS表总的Cronbach's系数为0.785。结论中文版HADS有较好的信度和效度,可作为健康体检中心筛查焦虑、抑郁的心理评估量表。

慢性阻塞性肺疾病患者抑郁、焦虑情绪调查

目的:发现慢性阻塞性肺疾病(COPD)病人伴抑郁、焦虑情绪的患病率,并分析其相关的影响因素。方法:对62例COPD患者进行了一般情况及医院焦虑抑郁量表(HospitalAnxietyandDepressionScale,HAD)问卷调查。结果:有抑郁情绪的患者42人(67.7%)。有焦虑情绪的患者的43人(69.3%)。14例III级COPD患者中达到抑郁、焦虑症状肯定存在标准的均有13人,高达92.8%。Logistic多因素回归分析,男性比女性病人更易出现抑郁和焦虑症状(OR值分别为1.05,95%CI1.01￣2.11,1.12,95%CI1.03￣2.23),肺功能差的患者更易出现抑郁和焦虑症状(OR值分别为2.34,95%CI1.98￣3.21,2.53,95%CI2.11￣4.01);对病情越了解的病人更易出现抑郁和焦虑症状(OR值分别为1.22,95%CI0.98￣1.54,1.25,95%CI1.01￣2.31)。结论:COPD患者中存在较高的抑郁及焦虑情绪障碍,肺功能受损程度是其主要影响因素。

慢性阻塞性肺疾病患者抑郁、焦虑情绪的影响及心理护理

目的调查我院慢性阻塞性肺疾病(COPD)住院病人发生抑郁、焦虑情绪的患病率,分析其相关的影响因素,探讨心理护理的意义。方法对79例COPD患者进行肺功能测试、一般情况登记及医院焦虑抑郁量表(HAD)问卷调查。对有焦虑、抑郁的COPD患者进行心理护理。结果 79例COPD患者中Ⅰ、Ⅱ、Ⅲ及Ⅳ级分别为11例、17例、22例和29例。79例患者中有抑郁情绪的54人(68.4%)。有焦虑情绪的56人(70.9%)。29例Ⅳ级COPD患者中达到抑郁、焦虑症状肯定存在标准的均有26人,高达89.7%。Logistic多因素回归分析,男性比女性病人更易出现焦虑和抑郁症状(OR值分别为1.07,95%CI 1.01～2.04;1.15,95%CI 1.02～2.25),肺功能差的患者更易出现焦虑和抑郁症状(OR值分别为2.36,95%CI 1.99～3.33;2.77,95%CI 2.21～4.04);对病情越了解的病人更易出现焦虑和抑郁症状(OR值分别为1.26,95%CI 0.99～1.62;1.27,95%CI 1.01～2.32)。结论 COPD患者中存在较高的抑郁及焦虑情绪障碍,肺功能受损程度是其主要影响因素。因此,对COPD患者的焦虑、抑郁状态早期识别并加以心理护理具有重要意义。

医院焦虑抑郁量表的因素结构研究

目的:探索和检验医院焦虑抑郁量表(HADS)在综合医院内科门诊样本中的因素结构。方法:采用探索性因素分析和验证性因素分析的方法评价HADS在综合医院内科门诊样本中的因素结构。结果:探索性主成分分析显示,HADS的因素结构与原作者Zigmond等(1983)的结构模型基本一致,由焦虑和抑郁两个因子组成;验证性因素分析也支持HADS双因子结构模型。结论:综合医院内科门诊患者HADS呈现焦虑和抑郁双因子结构,不同人群因子结构可能不同。

腹腔镜下卵巢囊肿切除术围手术期的中西医结合护理

目的:观察中西医结合护理干预对腹腔镜下卵巢囊肿切除术围手术期患者术后恢复的影响。方法:将144例行腹腔镜卵巢囊肿切除术治疗的患者随机分成对照组和观察组,每组72例。2组术后均予抗炎、补液等对症处理,对照组给予常规护理,观察组在常规护理基础上加中医护理。比较2组术后排气时间、下床时间及疼痛评分、抑郁量表(HADS-D)评分、焦虑量表(HADS-A)评分。结果:观察组的排气时间和下床时间均短于对照组,视觉模拟评分法(VAS)疼痛评分低于对照组,差异均有统计学意义(P<0.01)。观察组HADS-D及HADS-A评分均低于对照组,差异均有统计学意义(P<0.01)。结论:中西医结合护理干预腹腔镜下卵巢囊肿切除术围手术期患者,可改善患者的焦虑、抑郁状况,缓解术后疼痛。

黛力新在治疗慢性胃炎中的临床疗效观察

目的观察黛力新在治疗慢性胃炎中的临床疗效。方法选择80例经胃镜确诊为慢性胃炎患者,均伴有焦虑、抑郁,随机分成黛力新治疗组(D组)和对照组(C组)。黛力新治疗组患者晨起口服黛力新1片,1次/d;对照组:谷维素40mg,3次/d。4周后比较二组患者临床疗效。结果黛力新治疗组患者疗效好于对照组,无明显副作用。结论黛力新能快速高效改善焦虑、抑郁情绪,缓解消化道症状,且无明显不良反应。

健康干预活动对上海市浦东新区社区轻中度COPD患者焦虑、抑郁情况的影响

目的评估健康干预活动对社区轻中度慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患者心理焦虑、抑郁情况的影响。方法随机抽取上海市浦东新区10个社区作为研究现场,纳入社区内所有轻中度COPD患者作为研究对象。整群抽取其中4个社区所有研究对象行6个月的强化健康教育,设为干预组;其余6个社区作为对照组,针对组内所有研究对象进行一次常规健康教育。在基线和干预结束后分别进行基本信息问卷调查和焦虑/抑郁量表(The Hospital Anxiety and Depression Scale,HADS)调查,评价患者的焦虑、抑郁情况。结果共纳入464位COPD患者(干预组242人、对照组222人);最终完成随访282人(干预组155人、对照组127人),随访率60.8%。干预结果显示,干预活动提高了患者的规律用药比例(P=0.036,OR=2.24,95%CI:1.06-4.74)和对COPD的认知水平(P=0.019,OR=2.66,95%CI:1.18-6.03)。双重差分模型显示,干预活动对男性抑郁评分影响具有统计学意义(P=0.006,didt=-1.75);干预活动对男性焦虑评分和女性焦虑、抑郁评分的影响无统计学意义。结论干预活动缓解了上海市浦东新区轻中度男性COPD患者的抑郁情况,但对男性患者焦虑情况和女性患者焦虑、抑郁情况影响不大。社区COPD干预措施今后需要进一步改进,特别是针对女性患者。

从脾论治改善功能性腹泻患者生活质量分析

目的探讨从脾论治对功能性腹泻患者生活质量及相关影响因素的改善。方法60例功能性腹泻患者分为治疗组和对照组,治疗前后分别采用中医症状积分表、医院焦虑与抑郁量表(HAD)、SF-36生活质量量表进行评分,进行相关统计分析。结果治疗后两组中医症状积分比较有显著性差异(P<0.05)。HADA两组组内、治疗后组间比较有显著性差异(P<0.05)。两组SF-36心理维度积分、生活质量总评分有显著性差异(P<0.05)。单因素分析得出生理维度积分在性别、病程、证候分型方面有显著性差异(P<0.05),心里维度积分在病程有显著性差异(P<0.05),生活质量总评分在性别、病程、证候分型方面有显著性差异(P<0.05)。多元直线回归方程得出病程、焦虑积分、证候积分是心理维度及生活质量总评分的危险因素;而性别、病程、焦虑积分、证候积分是生理维度的危险因素。结论从脾论治功能性腹泻能够减少中医症状积分,减少焦虑积分,对功能性腹泻患者生活质量影响因素具有改善作用。

咽喉反流性疾病患者焦虑抑郁状况分析及其对疗效的影响

目的分析咽喉反流性疾病(Laryngopharyngealrefluxdisease,LPRD)患者的焦虑抑郁状况及其对疗效的影响。方法86例经反流症状评分表(Refluxsymptomindex,RSI)和反流体征评分表(Refluxfindingscore,RFS)证实为LPRD的患者(试验组)和90名健康志愿者(对照组)参与此项研究。采用医院焦虑抑郁量表(Hospital Anxiety and Depression Scale,HADS)对两组治疗前以及试验组质子泵抑制剂(Proton pump inhibitor,PPI)治疗后行问卷调查,评估并比较各组间的焦虑、抑郁状况,以及试验组焦虑、抑郁程度与疗效的相关性。结果试验组治疗前HADS量表抑郁分数为(12.89±5.73)分,高于对照组的(3.41±1.83)分,焦虑分数为(14.34±6.42)分,高于对照组的(4.53±2.16)分,两组比较差异有统计学意义(P<0.01);试验组治疗后HADS量表抑郁分数为(7.60±2.21)分,低于治疗前的(12.89±5.73)分,焦虑分数为(8.93±2.74)分,低于治疗前的(14.34±6.42)分,2组比较差异有统计学意义(P<0.01);相关性分析显示LPRD患者治疗前HADS评分与RSI及RFS评分呈显著正相关,治疗后HADS评分改善与RSI及RFS评分改善呈显著负相关。结论LPRD患者存在焦虑抑郁情绪,反流症状和体征越明显,其程度越严重,PPI治疗效果越差。

伴有心血管代谢疾病的眩晕患者的疗效影响因素

目的探讨伴有心血管代谢性疾病的眩晕/头晕患者的临床特征和近期结局影响因素。方法本研究纳入了2018年10月至2020年1月之间连续就诊于武汉同济医院眩晕专科门诊的伴有心血管代谢性疾病的眩晕/头晕患者。随访时获得的患者眩晕/头晕症状视觉模拟量表(Visual analogue scale,VAS)评分作为结局指标并按其分为完全缓解组和未完全缓解组,以t检验、Mann-Whitney U检验和χ2检验比较组间差异,近期结局影响因素通过线性回归模型进行评估。结果474名患者中女性多见(250名,60.5%)。在此群体中最常见的共患病是高血压(215[52.1%])。在没有纳入单纯BPPV患者的前提下,诊断以前庭型偏头痛(vestibular migraine,VM)最为常见,确定VM为149人(36.1%),其完全缓解率显著低于可能VM和本研究中其他眩晕/头晕疾病(P=0.028)。VAS评分从基线时的8分(四分位数间距:6-9分)下降至随访时的2分(四分位数间距:0-4分)。相较于未完全缓解组,完全缓解组中男性更多,具有更好的教育背景,HADS-D得分较低,VSS和DHI评分表明眩晕或头晕症状较轻,睡眠质量较好。多因素回归分析表明,基线时眩晕症状量表得分和医院焦虑抑郁量表的抑郁得分与随访的VAS评分之间具有显著相关性。结论伴有心血管代谢性疾病的眩晕/头晕患者的近期结局与就诊时症状严重程度和抑郁程度有独立相关性,医生有必要将情绪管理纳入综合治疗中。

孕期集体干预对产后抑郁症的影响

目的探讨孕期集体干预对产后抑郁症(PPD)的作用。方法选择在我院产检且分娩,在孕16~24周行医院焦虑-抑郁量表(HAD)筛查≥11分的438例孕妇为研究对象,分为干预组和非干预组。干预组孕妇从孕24周开始实施每周1次,每次90分钟,共6周的干预治疗,非干预组孕妇行常规孕期保健。所有研究对象在产后42天行爱丁堡产后抑郁量表(edinburgh postnatal depression scale,EPDS)测试≥12分诊断为产后抑郁症。结果干预组产后42天HAD≥11分(有焦虑或抑郁情绪)患者比率显著低于对照组(x^2=25.22,P<0.01)。干预组产妇EPDS值≥12分人数为22人,显著低于非干预组的63人,差异有统计学意义(x^2=24.51,P<0.01)。结论孕期集体干预能够缓解孕产妇焦虑-抑郁情绪,降低产后抑郁症发生率。

手术室护士进行术前访视干预对患者心理压力水平的影响研究

目的探析手术室护士进行术前访视干预对患者的术前心理压力水平的影响。方法选取2018年1月至2019年12月期间在我院接受手术治疗的患者共计179例,分为对照组93例,实验组86例。实验组接受手术室护士术前访视,对照组仅采取常规护理。采用问卷调查、患者满意度评分和医院用焦虑抑郁量表(HADS)收集研究数据,并比较两组患者的评分。结果实验组和对照组患者术前的平均心理压力水平没有差异(P=0.95),两组患者的术后压力水平均显著降低,但在术后发现了显着差异(P=0.01),术后实验组的心理压力水平明显低于对照组,HADS量表的最佳临界值为2。大多数患者表示由于即将进行的手术而感到压力,患者对引起压力的因素作了最常见的陈述为对未知的恐惧、麻醉恐惧、对手术中可能发生的环境和并发症的恐惧。实验组的患者报告说,手术室护士的访视有效地降低了他们的心理压力水平。结论术前手术室护士访视患者有助于降低患者的心理压力水平。

慢性阻塞性肺疾病合并焦虑、抑郁的情况调查

(1)目的探讨慢性阻塞性肺疾病(COPD)患者焦虑、抑郁的发生率及患者特点。(2)方法选取COPD患者154例,运用医院焦虑抑郁量表(Hospital Anxiety and Depression Scale,HADS)评估患者的焦虑、抑郁情况,分为焦虑抑郁组和非焦虑抑郁组,整理患者住院病历中记载的基本信息(包含性别、年龄、体质量指数、文化程度、急性加重次数、COPD病程、心血管疾病),并进行肺功能分级、呼吸困难评分(mMRC评分),分析COPD患者发生焦虑、抑郁的情况及这些患者的特点。(3)结果 COPD患者焦虑、抑郁的发生率为40.3%(62/154),两组患者的性别、年龄、体质量指数、文化程度、急性加重次数、COPD病程、心血管疾病病史和肺功能检查、mMRC评分比较,差异具有统计学意义(P<0.05)。(4)结论 COPD患者发生焦虑、抑郁的比例较高,且该类患者有比较明显的人口学特征和临床特征。

冠脉CTA检查在中低危的NSTEMI患者评估中的应用价值

目的探讨冠脉CT血管造影(CTA)检查在中低危的非ST段抬高型心肌梗死(NSTEMI)患者评估中的应用价值。方法选择2019年8月至2020年8月于延安大学咸阳医院诊治的154例中低危NSTEMI患者为研究对象,根据随机单双数法分为对照组和研究组各77例。对照组患者均安排行侵入性冠状动脉造影(ICA)检查,研究组患者先行冠脉CTA检查,如果检查结果显示冠状动脉重度及以上狭窄,则安排行ICA检查。比较两组患者的住院时间、住院费用、医院焦虑抑郁量表(HADS)评分、ICA阳性率;随访1年,比较两组患者的主要心血管事件(MACE)及其他严重不良事件。结果研究组患者的住院时间、住院费用及HADS评分分别为(3.74±1.05)d、(24522.45±7839.68)元、(8.76±2.65)分,明显少(低)于对照组的(4.88±1.54)d、(27321.27±8965.13)元、(11.52±3.12)分,差异均有统计学意义(P<0.05);研究组共有56例患者行ICA检查,ICA阳性率为94.64%(53/56),明显高于对照组的62.34%(48/77),差异有统计学意义(P<0.05);随访1年,两组患者的MACE及其他严重不良事件发生率比较差异均无统计学意义(P>0.05)。结论冠脉CTA检查在评估中低危NSTEMI患者需不需要行ICA检查的价值较高,能显著减少ICA检查的数量,并有效提高ICA阳性率,从而缩短患者住院时间,减少住院费用,改善其焦虑、抑郁心态。

Prevalence and Sex Distribution of Temporomandibular Disorder and Their Association with Anxiety and Depression in Indian Medical University Students

Objectives: The term TMD refers to a group of disorders characterized by pain in the temporomandibular joint and associated structures. The aim of this study was designed to evaluate prevalence, severity and sex distribution of sign and symptoms of TMD and to evaluate their relation with anxiety and depression among the students. Material and Methods: A total of 1000 university students were enrolled in the study (550 females;450 males), with ages ranged between 18 and 28 years. Helkimo anamnestic index (Ai) and clinical dysfunction index (Di) were used to determine symptoms and signs respectively. For the association of TMD with anxiety and depression, HAD (Hospital Anxiety and Depression) scale was used. Results showed that prevalence of one or more symptoms of TMD was 27.7%, while the prevalence of one or more signs of TMD was 64.4% which was mild in severity. Mild anamnestic symptoms (AiI) were found in 19.8% and severe symptoms (AiII) were found in 7.6%, while mild clinical sign (DiI), moderate clinical (DiII) and severe clinical sign (DiIII) were found in 49.7%, 12.2% and 2.4% respectively. Statistically there was no gender difference in these two scales. Regarding the association between TMD with anxiety and depression, 206 of the 311 students (66.2%) with TMD symptoms also had signs of anxiety and depression (P < 0.001). Conclusion: These findings confirmed that students had high prevalence of TMD which was significantly associated with anxiety and depression.

Is Cancer Still the Villain, Even during COVID 19 Outbreak?

Background :Anxiety and depression are two common psychiatric conditions encountered in cancer treatment. Prevalence rate and risk factors show wide variations in different countries and the environment. COVID 19 outbreak has increased psychological disorders in general public and health workers. Whether this pandemic has increased the psychiatric morbidity in cancer patients needs to be addressed for planning strategies. Methods: This cross-sectional study was conducted in the Department of Radiation Oncology, a tertiary cancer centre in the state of Kerala, India. The aim was to assess hospital prevalence and risk factors of anxiety and depression among cancer patients during COVID 19 pandemic. Patients on treatment for cancer and willing for the study were recruited. Hospital Anxiety and Depression Scale (HADS), a self-assessment valid tool for screening both anxiety (HADS-A) and depression (HADS-D) are used. HADS-A & D were calculated separately & categorized as normal, borderline and abnormal with a score of 0 - 7, 8 - 10 & 11 - 21 respectively. Separate structured questionnaire for COVID19 related questions and patient master file for patient & treatment characteristics were used in risk assessment. Data were entered in an Excel sheet and SPSS version 22 for statistical analysis. Findings: 208 patients were included in this study. The overall prevalence rate of anxiety was 7.2%, with borderline cases 4.3% and abnormal cases 2.9%. The overall prevalence of the rate of depression was 5.3% (3.4% borderline & 1.9% abnormal). Risk factors like age, sex, socioeconomic status, primary site, stage of the disease and default of disease had no statistical significance. Interpretation: The prevalence rate of anxiety and depression among cancer patients in this study is one among the lowest ever reported. COVID 19 outbreak has not brought any impact in the rate of psychological distress in our patients and the low rate may be due to the robust medical care including mental health interventions and reassurance by the Government.